Context Therapeutics® Strengthens Research & Development Team

January 5, 2022 News 0

PHILADELPHIA, Jan. 05, 2022 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological